Information  X 
Enter a valid email address

EPIC/TIDM matching '0P3C'

Date
Time Source
Company
Announcement
05 Sep 2018 8:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Vesalius Biocapital III Partners invests in Karolinska Development's portfolio company Forendo Pharma
04 Jul 2018 8:02 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's portfolio company Forendo Pharma initiates clinical phase I study for endometriosis treatment
17 Jun 2018 5:05 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II combination study with APR-246 at hematology congress
31 May 2018 8:34 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's portfolio company Pharmanest out-licenses Canadian rights for SHACT to Acerus
21 May 2018 2:01 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's portfolio company Pharmanest appoints new CEO
18 Apr 2018 3:28 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's portfolio company Modus Therapeutics' sevuparin granted Rare Pediatric Disease Designation from FDA for the treatment of sickle cell disease
06 Apr 2018 7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Asarina Pharma announces the start of a clinical Phase IIB study in patients with premenstrual dysphoric disorder
19 Mar 2018 8:30 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's portfolio company Forendo Pharma granted a €3 million loan
15 Mar 2018 7:30 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's portfolio company Modus Therapeutics appoints a new Chief Medical Officer
07 Mar 2018 9:18 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's portfolio company Forendo Pharma announces the appointment of David Colpman to its Board of Directors
21 Dec 2017 2:23 pm GNW Factsheet Karolinska Development AB (pub (0P3C) BioArctic, a company in Karolinska Development's portfolio, announces that the Phase 2b study of BAN2401 in early Alzheimer's Disease continues toward 18-month endpoint 
20 Dec 2017 9:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's portfolio company Modus Therapeutics announces publication of Phase I/II data demonstrating anti-adhesive properties of sevuparin
14 Dec 2017 7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's portfolio company Promimic receives FDA approval for HAnano Surface for use on dental implants
13 Dec 2017 7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development divests its holding in Lipidor
28 Nov 2017 6:00 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development announces outcome of the Extraordinary General Meeting
20 Nov 2017 7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Umecrine Cognition announces first patient included in clinical Phase 2a study in patients with sleep disorder
09 Nov 2017 1:45 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development will receive shares in Pharmanest AB
06 Nov 2017 7:00 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development realizes value increase in the portfolio company BioArctic through a partial exit and receives SEK 35 million
03 Nov 2017 6:00 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Notice of EGM in Karolinska Development AB
31 Oct 2017 7:30 am GNW Factsheet Karolinska Development AB (pub (0P3C) Change of Number of Shares and Votes in Karolinska Development
  7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development publishes Interim Report (January - September 2017) and reports a positive result for the third quarter
  7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Changes in the Board of Directors at Karolinska Development
30 Oct 2017 7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development divests its holdings in Xspray and receives SEK 12.5 million directly and additionally SEK 0.8 million via KCIF's sale
27 Oct 2017 6:09 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development divests its holdings in Xspray and receives SEK 12.5 million directly and additionally SEK 0.8 million via KCIF's sale
  7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development - Interim Report (January-September 2017) - Invitation to conference call and webcast
16 Oct 2017 7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's portfolio company Aprea announces first patient enrolled in clinical phase 1b/2 study with APR-246 for the treatment of esophageal cancer
  7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) The value of Karolinska Development's holdings in Umecrine Cognition increases with SEK 196 million owing to positive phase 1b data
12 Oct 2017 7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) First day of trading in Karolinska Development's portfolio company BioArctic's shares on Nasdaq Stockholm
04 Oct 2017 7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's portfolio company Umecrine Cognition secures financing for clinical development of the drug candidate GR3027 against sleep disorders
28 Sep 2017 7:50 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's former portfolio company Xspray Pharma is listed on Nasdaq First North
14 Sep 2017 7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Developments's portfolio company Modus Therapeutics recruits new Chief Medical Officer
13 Sep 2017 7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's portfolio company BioArctic intends to list on Nasdaq Stockholm
  7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's portfolio company Umecrine Cognition presents positive phase 1b data for its drug candidate against hepatic encephalopathy
05 Sep 2017 10:13 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development company Umecrine Cognition appoints Dr. Thomas P. Blackburn to its board of directors
31 Aug 2017 7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Change of Number of Shares and Votes in Karolinska Development
29 Aug 2017 5:00 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development: Interim Report - January-June 2017
  4:45 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development Appoints Fredrik Järrsten as Chief Financial Officer
25 Aug 2017 12:00 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development Notes the Planned Listing of Xspray AB on Nasdaq First North
24 Aug 2017 7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development - Interim Report (January-June 2017) - Invitation to conference call and webcast
02 Aug 2017 8:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development company Aprea Therapeutics announces First Patient Enrolled in Phase Ib/II Clinical Study
24 May 2017 7:00 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development's Annual General Meeting 2017
16 May 2017 5:00 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development: Interim Report - January-March 2017
12 May 2017 7:01 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development - Q1 2017 Report - invitation to conference call and webcast
28 Apr 2017 7:00 am GNW Factsheet Karolinska Development AB (pub (0P3C) Change of Number of Shares and Votes in Karolinska Development
20 Apr 2017 7:03 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development announces Chairman Bo Jesper Hansen and CEO Jim Van heusden's decision to Step Down, and the promotion of Viktor Drvota to CEO
  7:02 am GNW Factsheet Karolinska Development AB (pub (0P3C) Notice of Annual General Meeting in Karolinska Development AB (publ)
05 Apr 2017 7:01 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development announces outcome of set-off issue
17 Mar 2017 7:02 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development publishes prospectus relating to set off issue
08 Mar 2017 5:30 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development announces outcome of the Extraordinary General Meeting
06 Mar 2017 5:30 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Announcement of the Final Terms and Conditions of Karolinska Development's Set-off Issue
22 Feb 2017 1:00 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development - Q4 and 2016 Year-End Report - invitation to conference call and webcast
07 Feb 2017 12:14 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Correction of error in press release regarding convening notice to the EGM
06 Feb 2017 9:07 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Notice of Extraordinary General Meeting in Karolinska Development AB (publ)
  8:35 pm GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development - Offer on a set-off share issue to convertible holders to strengthen the Company's equity position
22 Feb 2012 7:31 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development AB (publ) - Year-End Rep...
21 Feb 2012 7:31 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development - Year-End Report, confe...
  7:01 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development invests in Oss-Q
14 Feb 2012 7:02 am GNW Factsheet Karolinska Development AB (pub (0P3C) KDev Oncology AB invests in GliGene AB
13 Feb 2012 7:02 am GNW Factsheet Karolinska Development AB (pub (0P3C) Karolinska Development announces the formation ...
10 Feb 2012 6:01 am GNW Factsheet Karolinska Development AB (pub (0P3C) Pergamum completes patient recruitment to the P...


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t